Skip to search formSkip to main contentSkip to account menu

Trimovax

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Measles-Mumps-Rubella Vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Immunogenicity and safety of a varicella vaccine (Okavax) and a trivalent measles, mumps, and rubella vaccine (Trimovax) administered concomitantly in healthy Filipino children 12-24 months old.
The immunogenicity and safety of Okavax trade mark varicella vaccine, when administered concomitantly with Trimovax trade mark… 
2000
2000
The immunogenicity and reactogenicity of the trivalent vaccine, Trimovax, indicated for prevention of measles, mumps, and rubella, in 12-month-old children in Belarus.
In the Republic of Belarus, immunization of children against measles and mumps had been carried out using monovalent preparations… 
1998
1998
[The immunological efficacy of the combined vaccine Trimovax intended for the prevention of measles, mumps and rubella].
In 1996 the immunization of children against measles, mumps and rubella with combined vaccine Trimovax ("Pasteur Mérieux… 
1989
1989
An evaluation of measles, mumps and rubella vaccine in a population of Yorkshire infants.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)